Application Nr Approved Date Route Status External Links
ANDA207760 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Bosentan Tablets Are Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1): In Adults To Improve Exercise Ability And To Decrease Clinical Worsening. Studies Establishing Effectiveness Included Predominantly Patients With Who Functional Class Ii-Iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah (60%), Pah Associated With Connective Tissue Diseases (21%), And Pah Associated With Congenital Heart Disease With Left-To-Right Shunts (18%) [See Clinical Studies ( 14.1 )] . Bosentan Tablets Are An Endothelin Receptor Antagonist Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1): In Adults To Improve Exercise Ability And To Decrease Clinical Worsening. Studies Establishing Effectiveness Included Predominantly Patients With Who Functional Class Ii-Iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah (60%), Pah Associated With Connective Tissue Diseases (21%), And Pah Associated With Congenital Heart Disease With Left-To-Right Shunts (18%) ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bosentan BOSENTAN ZINC1538857

Comments